Health and Healthcare

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag.  GlaxoSmithkline (GSK) saw the lagest increase, but its short interest is not representative of its real size or activity because it is an ADR and less active here compared to U.K. trade volume.  We ranked hese in terms of percentages with the largest increase in short interest first.

STOCK (Ticker)                JUNE07      MAY07     Change
GlaxoSmithkline (GSK)     7.74M         4.15M       +86%
Boston Scientific (BSX)   32.07M       24.06M       +33.3%
Wyeth (WYE)                          3.3M       10.37M       +28.3%
Labcorp (LH)                       4.11M         3.21M       +28%
Bristol-Myers (BMY)          26.95M       23.85M      +13%
Schering-Plough (SGP)   16.79M      15.27M       +9.9%
Medtronic (MDT)                16.11M      15.19M        +6%
Pfizer (PFE)                        54.48M       52.12M       +4.5%
Quest Diagnost. (DGX)    18.00M       17.54M       +2.6%
Merck (MRK)                       22.82M       22.55M       +1.2%
Eli Lilly (LLY)                       13.77M       14.07M        -2.1%
J&J (JNJ)                             15.37M      16.16M        -4.9%
Zimmer Holdings (ZMH)     3.89M         4.13M        -5.8%
St. Jude MEdical (STJ)        6.53M         7.13M         -8.4%
Genentech (DNA)                 6.87M         8.16M        -15.9%
Abbott Labs (ABT)              11.74M       16.39M        -28.3%

Jon C. Ogg
June 24, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.

Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)

Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.

Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.

Click here now to get started.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.